Gujarat Cancer and Research Institute Treats over 4,300 patients in 4 years - Video
Overview
Gujarat Cancer and Research Institute Treats over 4,300 patients in 4 years, urges early screening
The Gujarat Cancer and Research Institute (GCRI) in Ahmedabad has treated 4,397 cancer patients between 2020 and 2024, reinforcing the state's emergence as a national hub for advanced lung cancer treatment.
Of these, 3,256 patients benefited from the PMJAY-MA health scheme, underscoring the state’s commitment to affordable, high-quality cancer care.
Speaking on World Lung Cancer Day, GCRI officials urged the public to prioritise early screening and tobacco cessation, stressing that over 40 per cent of cases in India are diagnosed at late stages, significantly reducing survival chances, news agency IANS reported.
GCRI Director Dr. Shashank Pandya emphasised, “Awareness is our greatest defence. Early detection, quitting tobacco, and timely care can save lives.”
The annual number of patients seeking treatment at GCRI has seen a steady rise: 700 in 2020, 813 in 2021, 865 in 2022, 933 in 2023 and 1,086 in 2024. Among the 4,397 patients treated, 3,597 were men, 799 were women, and one child, with 1,426 patients coming from other Indian states—further validating Gujarat’s growing reputation in cancer care.
For more information, click on the link below:
Gujarat Cancer and Research Institute Treats over 4,300 patients in 4 years, urges early screening
Speakers
